Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARCOS JAVIER CRUZ

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1265556898
CMS profile
239271
Location
GUAYNABO, PR

General Payments · PY2018–2024

$6,988.87

  • Reported across 477 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$543.87

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $543.87 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,264.90 104
PY2019 $1,254.15 104
PY2020 $1,741.69 120
PY2021 $1,138.31 83
PY2022 $641.52 35
PY2023 $404.43 16
PY2024 $543.87 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.19 11/13/2024 Food and Beverage Undisputed 01/23/2026 1124936674 CMS
Biogen, Inc. $16.97 08/27/2024 Food and Beverage Undisputed 01/23/2026 1104855390 CMS
CATALYST PHARMACEUTICALS, INC. $17.82 04/08/2024 Food and Beverage Undisputed 01/23/2026 1144447800 CMS
CATALYST PHARMACEUTICALS, INC. $19.59 06/25/2024 Food and Beverage Undisputed 01/23/2026 1144447802 CMS
CATALYST PHARMACEUTICALS, INC. $21.31 08/20/2024 Food and Beverage Undisputed 01/23/2026 1144447804 CMS
Eisai Inc. $22.93 04/03/2024 Food and Beverage Undisputed 01/23/2026 1110762803 CMS
Eisai Inc. $123.79 10/03/2024 Food and Beverage Undisputed 01/23/2026 1110762805 CMS
JAZZ PHARMACEUTICALS INC. $150.00 11/14/2024 Food and Beverage Undisputed 01/23/2026 1150206957 CMS
Lilly USA, LLC $24.98 09/11/2024 Food and Beverage Undisputed 01/23/2026 1135150894 CMS
Otsuka America Pharmaceutical, Inc. $16.67 06/27/2024 Food and Beverage Undisputed 01/23/2026 1118880458 CMS
Sumitomo Pharma America, Inc. $15.55 01/18/2024 Food and Beverage Undisputed 01/23/2026 1148841756 CMS
Sumitomo Pharma America, Inc. $21.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1148841758 CMS
Sumitomo Pharma America, Inc. $20.07 03/18/2024 Food and Beverage Undisputed 01/23/2026 1148841760 CMS
Supernus Pharmaceuticals, Inc. $42.80 01/30/2024 Food and Beverage Undisputed 01/23/2026 1147876983 CMS
Supernus Pharmaceuticals, Inc. $14.07 08/07/2024 Food and Beverage Undisputed 01/23/2026 1147876981 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.